Recombinant Anti-CD19× Anti-CD3 Bi-specific T-cell engagers (Tandem Diabody) (CAT#: BSAB-L011)

Recombinant Anti-CD19 × Anti-CD3 Bispecific Antibody (Tandem Diabody). This bsAb has been generated by applying the Crossmab format to generate an IgGshaped entity that binds each ligand with one arm. The complex is capable of Retargeting of T cells to tumor. It was designed for the treatment of NHL and ALL.


Specific Inquiry
  • Size:
  • Conjugation:
  • Datasheet
  • MSDS
  • COA

Specifications

  • Target
  • CD19 & CD3
  • Type
  • Tandem Diabody
  • Species Reactivity
  • Human
  • Target 1
  • CD19
  • Host Species 1
  • Humanized
  • Target 2
  • CD3
  • Host Species 2
  • Mouse
  • Related Disease
  • ALL (acute lymphoblastic leukemia), NHL (non-hodgkin lymphoma)

Target

  • Target 1
  • CD19
  • Alternative Names
  • B4; CVID3
  • Target 2
  • CD3
  • Alternative Names
  • CD3; cluster of differentiation 3; CD3γ; CD3δ; CD3ε; CD3ζ

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "CD19 & CD3"

CrossMab

CAT Product Name Application Type
CROSS-L024 Recombinant Anti-CD19 × Anti-CD3 Bispecific Antibody (CrossMab) FuncS, Promising therapeutic agent CrossMab

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for BSAB-L011. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare